The Natriuretic Peptide Family: ANP, BNP, CNP and the Shared cGMP System

The Family That Speaks One Chemical Language

Three peptides, three separate genes, one shared message. The natriuretic peptide family is one of biology's cleaner examples of how a single second-messenger system gets reused for very different jobs — fluid balance, blood-vessel tone, and even the growth of long bones. The peptides that carry those signals are supplied by Optides for research use only, and everything below describes what has been observed in cell-culture and animal studies, not in people.

If you're researching this corner of signaling biology, there's a real payoff: a mental model you can reuse. Learn how one receptor turns a peptide into cyclic GMP, and you have most of the framework for the whole family. This explainer meets the three peptides, sorts out the three receptors that read them, walks through the guanylyl-cyclase switch they share, and closes on why that small messenger draws so much research interest.

Meet the Family: ANP, BNP, and CNP

The short version: the three natriuretic peptides look like relatives but are transcribed from different genes on different chromosomes. Atrial natriuretic peptide (ANP) is a 28-amino-acid peptide from the NPPA gene on chromosome 1p36. B-type natriuretic peptide (BNP) comes from NPPB, also on 1p36. C-type natriuretic peptide (CNP) is encoded by NPPC over on chromosome 2. Each one is cut from its own precursor prohormone before it becomes the active molecule (gene and chromosome assignments).

What ties them together is a piece of shared architecture: a 17-amino-acid ring closed by a disulfide bond between two cysteine residues. That conserved loop is the part the receptors recognize; the peptides differ mostly in the tails that hang off the ring. In this respect the natriuretic peptides behave like other receptor-defined groups — much the way the incretin peptide class gathers GLP-1 and GIP as gene-distinct molecules that share a functional theme rather than a single origin.

Their primary research associations split along tissue lines. ANP and BNP show up mostly in cardiovascular and renal contexts — the heart releases them under stretch and pressure. CNP behaves differently. It's found in blood vessels, brain, and, importantly, cartilage, where it acts as a local signal rather than a circulating hormone.

One Signal, Three Receptors: NPR-A, NPR-B, NPR-C

The plain-English answer first: the family talks to three receptors, but only two of them actually generate a signal inside the cell. Sorting out which peptide binds which receptor is the key to the whole system.

The two signaling receptors

Natriuretic peptide receptor-A (NPR-A), also called guanylyl cyclase-A (GC-A), is the principal receptor for ANP and BNP. CNP, meanwhile, is read by natriuretic peptide receptor-B (NPR-B / GC-B). Both are single-pass membrane proteins whose inside end is an enzyme — a guanylyl cyclase — so binding a peptide on the outside directly switches on catalytic activity within (NPR-A signaling review).

The clearance receptor

The third receptor, NPR-C, is the odd one out. It has no guanylyl cyclase domain, so it makes no cyclic GMP. Instead it works largely as a clearance receptor: it binds circulating peptides and pulls them out of the extracellular space, helping set how much signal ever reaches the two enzyme-linked receptors. Think of it as a volume knob on the whole system. A single peptide family read by a small panel of receptor subtypes is a recurring pattern in signaling biology — the melanocortin receptor family is another well-mapped case of one ligand group spread across several receptors with different jobs.

cGMP: The Shared Second Messenger

Here's what actually happens in the instant a peptide binds. The extracellular domain of NPR-A or NPR-B changes shape, and that shift is relayed through the membrane to the guanylyl cyclase domain inside the cell. The enzyme then converts GTP into cyclic guanosine monophosphate — cGMP — the family's shared second messenger. One detail worth flagging: full activation also needs ATP bound to a kinase-homology region of the receptor, which primes the cyclase to fire (receptor activation mechanics).

Once cGMP rises, it fans out to three classes of effector: cGMP-dependent protein kinases (PKGs), cGMP-regulated phosphodiesterases (PDEs), and cGMP-gated ion channels. That's how one binding event at the surface becomes a broad change in cell behavior. If the logic feels familiar, it should — it mirrors cyclic-nucleotide signaling like cAMP, where a different cyclase makes a different cyclic nucleotide to drive its own set of kinases. Same playbook, different nucleotide.

Downstream Effectors: What cGMP Switches Off

Much of the natriuretic system's character comes from what cGMP quiets rather than what it turns up. In research models, the ANP → NPR-A → cGMP → PKG cascade antagonizes phosphoinositide hydrolysis, blunts intracellular calcium release, and lowers protein kinase C (PKC) activity (signaling antagonism study). In cultured vascular smooth muscle cells, cGMP switches on a sarcolemmal calcium-ATPase that lowers cytosolic calcium — a plausible mechanism behind the vasorelaxant, antiproliferative behavior seen in vitro.

The same review reports that in these models NPR-A activation dampens pro-inflammatory cytokines — TNF-α, IL-1β, and IL-6 — through inhibition of NF-κB, and that it antagonizes the renin-angiotensin-aldosterone axis by suppressing renin and aldosterone. Genetic work adds a striking data point: mice lacking NPR-A develop cardiac hypertrophy and fibrosis independent of blood pressure, which points to a tissue-protective role for the receptor itself rather than a purely hemodynamic effect (NPR-A knockout findings). Read together, these results frame the cGMP arm as an "off switch" for several stress and proliferation pathways in the laboratory.

CNP and NPR-B: The Bone-Growth Axis

CNP tells a different story, and it's one of the more surprising branches of the family. Signaling through NPR-B (GC-B), CNP is a pivotal stimulator of endochondral bone growth in research models — the process by which cartilage templates lengthen and turn into long bone (local CNP/GC-B system in the growth plate).

Human genetics makes the point vividly. Loss-of-function variants in NPR-B, and in the CNP gene itself, are associated with autosomal-dominant short stature, while gain-of-function variants in NPR-B and elevated CNP expression track with skeletal overgrowth. Mechanistically, CNP expands the hypertrophic zone of the growth plate and delays mineralization; both effects vanish when p38 MAP kinase is inhibited, and CNP additionally engages a cAMP/PKA arm that helps lengthen the hypertrophic zone (CNP and endochondral growth). The takeaway researchers draw is that it's the local CNP/GC-B system, not circulating peptide, that drives physiological long-bone growth. As always, these are observations from cell and animal models, not statements about human use.

Why the cGMP Axis Draws Research Interest

Part of the interest is practical. Because ANP and BNP expression climbs when the heart is under stress, and because BNP has a longer circulating half-life (~12-20 minutes) than ANP (~0.5-4 minutes), BNP and its precursor fragment NT-proBNP are simply more stable to measure — which is why they became established biomarkers in heart-failure research and clinical diagnosis. That's a fact about the molecules, not a claim about any Optides product.

The deeper interest is conceptual. Here is one small nucleotide switch, cGMP, tuned across fluid balance, vascular tone, bone growth, inflammation, and even metabolism, with the outcome in each tissue set by which downstream effectors are wired in. That modularity is why the system keeps showing up as a reference model when researchers map receptor-guanylyl-cyclase signaling. It also explains the attention on neprilysin — the enzyme that degrades natriuretic peptides — as a lever on endogenous peptide levels. For readers who prefer to explore biology by receptor rather than by molecule, other receptor-defined peptide classes make good companion reading.

Frequently Asked Questions

What are the three natriuretic peptides?

The family has three members — atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP), and C-type natriuretic peptide (CNP). Each is encoded by a separate gene (NPPA, NPPB, and NPPC) and processed from its own precursor prohormone, so although the three share a conserved 17-amino-acid ring closed by a disulfide bond, they are distinct molecules with distinct primary roles in research models.

How do natriuretic peptides use cGMP?

ANP, BNP, and CNP bind membrane receptors whose intracellular portion is a guanylyl cyclase enzyme. When a peptide binds, that enzyme converts GTP into cyclic GMP (cGMP), the family's shared second messenger. Rising cGMP then activates cGMP-dependent protein kinases (PKGs), cGMP-regulated phosphodiesterases, and cGMP-gated ion channels, which is how a single binding event is translated into a broader cellular response in laboratory studies.

What is the difference between NPR-A, NPR-B, and NPR-C?

NPR-A (guanylyl cyclase-A) is the main receptor for ANP and BNP; NPR-B (guanylyl cyclase-B) is the receptor for CNP. Both generate cGMP. NPR-C is different — it lacks a guanylyl cyclase domain and functions largely as a clearance receptor, binding peptides and removing them from circulation to help set how much signal reaches the cGMP-producing receptors.

Why is BNP measured in heart-failure research?

In cardiac stress, expression of ANP and BNP rises as a compensatory response, and BNP has a longer circulating half-life (~12-20 minutes) than ANP (~0.5-4 minutes), which makes it more stable to measure. Elevated BNP and its precursor fragment NT-proBNP are established biomarkers used clinically to help diagnose and gauge the severity of heart failure. Optides supplies related peptides for research use only and makes no diagnostic claims.

Putting It All Together

One family, three peptides, three receptors, and a single shared chemical language. The elegance of the natriuretic peptide system is its reuse: the same cGMP switch sits behind ANP's role in fluid balance, BNP's role as a stress signal, and CNP's role in bone growth — the difference lies entirely in which downstream wiring each tissue plugs into. As research keeps mapping the cGMP interactome, the natriuretic system stays a clean reference point for how a receptor-guanylyl-cyclase pair turns a peptide into a broad cellular response. For more on how related families are organized by their receptors, the companion explainers linked above are a good next step.

For research use only. Not for human or animal consumption of any kind. The information in this article is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. The statements made have not been evaluated by the U.S. Food and Drug Administration. These products are NOT FDA APPROVED. Please consult with a licensed healthcare professional before making any decisions regarding your health or research.

Optides LLC is a chemical supplier. Optides LLC is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Optides LLC is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.